NCT06899906
- Conditions
- Efficacy and Safety of Dalbavancin, For Acute or Chronic Infections Between July 2019 and December 2024, In Subjects Who Received SAT with DAL
- Locations
-
- HCL France, Lyon
Clinical trial condition
Efficacy and Safety of Dalbavancin
Explore clinical trials studying Efficacy and Safety of Dalbavancin. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study